Liminatus Pharma Inc (LIMN)

$8.04 -2.03 (-20.16%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 96,300
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Liminatus Pharma, Inc., a pre-clinical stage biopharmaceutical company, engages in the development of cancer therapies in the United States. It develops IBA101, a humanized anti CD47 monoclonal antibody, which is in Phase I clinical trial for the treatment of advanced solid cancers, including non-small cell lung cancer. The company was founded in 2018 and is based in Cerritos, California.

Industry: Biotechnology
Sector: Healthcare
Phone: 213 273 5453
Address:
12611 Hiddencreek Way, Unit C, Cerritos, United States
borngifted10
borngifted10 Aug. 31 at 6:28 AM
$LIMN we are just getting murdered
0 · Reply
TNNStockAnalysisNews
TNNStockAnalysisNews Aug. 31 at 1:53 AM
Stocks Under $1 to Watch Tomorrow: Monday, August 31, 2026 $IVDA — $0.33 | Drone Line Launch Meets a Brutal 52-Week Range $LIMN — $0.18 | A Cancer Biotech Pivoting Into BNB Treasury $OTLK — $0.68 | An FDA Win Overshadowed by a Revenue Miss $ELBM — $0.63 | A Cobalt Refinery Locking In Long-Term Supply $AIM — $0.28 | An Earnings Report That Could Break the Recent Uptrend https://truthsandnews.com/markets/stocks-under-1-to-watch-this-week-aug-31-2026
0 · Reply
Najoua233902
Najoua233902 Aug. 29 at 9:35 PM
$LIMN remembered this had crazy runs before any one that traded this will know how high this went did run 1000% I Remeber
0 · Reply
The_Claw
The_Claw Aug. 28 at 8:09 PM
$LIMN Ballz is down 40% and is talking like he alone can read the tea leaves.
0 · Reply
skeezymonet
skeezymonet Aug. 28 at 5:56 PM
$LIMN at this point the September 3 Nasdaq deadline might be a light at the end of the tunnel. But thats pure hopium junkie
0 · Reply
Magik8ball2
Magik8ball2 Aug. 28 at 2:33 PM
$LIMN So this is stuck around $4.50. We need news.
1 · Reply
SHRTSQZ
SHRTSQZ Aug. 27 at 9:22 PM
$LIMN
0 · Reply
Najoua233902
Najoua233902 Aug. 27 at 2:16 PM
$YMT accumulating will shoots up as soon as the float is locked in so far so good $LIMN bottom is in $BYAH
0 · Reply
Candyfan
Candyfan Aug. 26 at 6:39 PM
$LIMN - this one will run soon, patience
2 · Reply
The_Claw
The_Claw Aug. 26 at 5:35 AM
$LIMN Cure for cancer?! $375/share?! Recovery? That pumper guy is outdoing himself.
2 · Reply
Latest News on LIMN
Liminatus Pharma engages Synex Consulting to support IBC101 development

2026-08-24T12:05:17.000Z - 7 days ago

Liminatus Pharma engages Synex Consulting to support IBC101 development

Liminatus Pharma Engages Synex as Contract Research Organization to Support Phase 1/2a Clinical Development of CD19xCD22 bivalent CAR-T therapy

Aug 24, 2026, 8:00 AM EDT - 7 days ago

Liminatus Pharma Engages Synex as Contract Research Organization to Support Phase 1/2a Clinical Development of CD19xCD22 bivalent CAR-T therapy

Liminatus Pharma Inc trading halted, news pending

2026-08-20T23:50:20.000Z - 10 days ago

Liminatus Pharma Inc trading halted, news pending

Liminatus Pharma announces 1-for-50 reverse stock split

2026-08-18T20:10:46.000Z - 12 days ago

Liminatus Pharma announces 1-for-50 reverse stock split

Liminatus Pharma, Inc. Announces Reverse Stock Split of its Common Stock

Aug 18, 2026, 4:01 PM EDT - 12 days ago

Liminatus Pharma, Inc. Announces Reverse Stock Split of its Common Stock

Liminatus Pharma (LIMN) Stock Jumps Over 50% on a Listing Update

2026-08-13T18:11:48.000Z - 17 days ago

Liminatus Pharma (LIMN) Stock Jumps Over 50% on a Listing Update

Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Compliance with Minimum Bid Price Requirement

Aug 13, 2026, 7:15 AM EDT - 18 days ago

Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Compliance with Minimum Bid Price Requirement

Liminatus Pharma amends, restates merger agreement with InnocsAI

2026-06-30T20:35:21.000Z - 2 months ago

Liminatus Pharma amends, restates merger agreement with InnocsAI

Liminatus Pharma Amends Definitive Merger Agreement with InnocsAI to Expand Oncology Cell Therapy Pipeline

Jun 30, 2026, 4:30 PM EDT - 2 months ago

Liminatus Pharma Amends Definitive Merger Agreement with InnocsAI to Expand Oncology Cell Therapy Pipeline

Liminatus Pharma files to sell 20.69M shares of common stock for holders

2026-06-24T10:05:11.000Z - 2 months ago

Liminatus Pharma files to sell 20.69M shares of common stock for holders

Liminatus Pharma Enters Into Warrant Exercise Transaction for $1.9 Million in Gross Proceeds

Jun 3, 2026, 8:30 AM EDT - 3 months ago

Liminatus Pharma Enters Into Warrant Exercise Transaction for $1.9 Million in Gross Proceeds

Liminatus Pharma receives Nasdaq delisting notice

2026-05-22T09:50:47.000Z - 3 months ago

Liminatus Pharma receives Nasdaq delisting notice

Liminatus Pharma Announces Nasdaq Delisting Notification

May 21, 2026, 8:28 PM EDT - 3 months ago

Liminatus Pharma Announces Nasdaq Delisting Notification

Liminatus Pharma to initiate Phase 1 clinical trial for IBA101 antibody

2026-03-17T12:16:31.000Z - 5 months ago

Liminatus Pharma to initiate Phase 1 clinical trial for IBA101 antibody

Liminatus Pharma Announces Planned Phase 1 Clinical Trial of IBA101, a Next-Generation CD47 Blocking Antibody

Mar 17, 2026, 8:08 AM EDT - 5 months ago

Liminatus Pharma Announces Planned Phase 1 Clinical Trial of IBA101, a Next-Generation CD47 Blocking Antibody

Liminatus Pharma prices 13.8M shares at 29c in public offering

2026-02-17T13:55:30.000Z - 6 months ago

Liminatus Pharma prices 13.8M shares at 29c in public offering

Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering

Feb 17, 2026, 8:44 AM EST - 6 months ago

Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering

Liminatus Pharma files to sell 6.9M shares of common stock, warrants

2026-02-11T11:16:00.000Z - 7 months ago

Liminatus Pharma files to sell 6.9M shares of common stock, warrants

Liminatus Pharma, Inc. (NASDAQ: LIMN) Signs MOU with Capital Trust Group for USD 30 Million Equity Investment via an earn-out mechanism and Future Strategic Cooperation

Oct 30, 2025, 10:04 AM EDT - 10 months ago

Liminatus Pharma, Inc. (NASDAQ: LIMN) Signs MOU with Capital Trust Group for USD 30 Million Equity Investment via an earn-out mechanism and Future Strategic Cooperation

Liminatus Pharma Inc trading resumes

2025-08-04T17:30:33.000Z - 1 year ago

Liminatus Pharma Inc trading resumes

Liminatus Pharma Inc trading halted, volatility trading pause

2025-08-04T17:25:16.000Z - 1 year ago

Liminatus Pharma Inc trading halted, volatility trading pause

Liminatus Pharma to launch ‘American BNB Strategy’ subsidiary

2025-07-28T11:35:07.000Z - 1 year ago

Liminatus Pharma to launch ‘American BNB Strategy’ subsidiary

Liminatus Pharma Inc. to Launch “American BNB Strategy” Subsidiary and Target Up To $500 Million Fund for BNB Investment as Part of Crypto Market Initiative

Jul 28, 2025, 7:30 AM EDT - 1 year ago

Liminatus Pharma Inc. to Launch “American BNB Strategy” Subsidiary and Target Up To $500 Million Fund for BNB Investment as Part of Crypto Market Initiative

Liminatus Pharma evaluates formation of digital asset investment vehicle

2025-07-25T12:40:53.000Z - 1 year ago

Liminatus Pharma evaluates formation of digital asset investment vehicle

Liminatus Pharma Inc. Evaluates Formation of Digital Asset Investment Vehicle Targeting Up To $500 Million in Capital Strategies

Jul 25, 2025, 8:31 AM EDT - 1 year ago

Liminatus Pharma Inc. Evaluates Formation of Digital Asset Investment Vehicle Targeting Up To $500 Million in Capital Strategies

Liminatus Pharma entered into engagement agreement with Digital Offering

2025-07-24T12:51:27.000Z - 1 year ago

Liminatus Pharma entered into engagement agreement with Digital Offering

Liminatus Pharma Inc. Takes Next Step in Evaluating Digital Asset-Linked Capital Strategy

Jul 24, 2025, 8:31 AM EDT - 1 year ago

Liminatus Pharma Inc. Takes Next Step in Evaluating Digital Asset-Linked Capital Strategy

Liminatus Pharma Inc trading resumes

2025-07-22T17:45:39.000Z - 1 year ago

Liminatus Pharma Inc trading resumes

Liminatus Pharma Inc trading halted, volatility trading pause

2025-07-22T17:35:35.000Z - 1 year ago

Liminatus Pharma Inc trading halted, volatility trading pause

Liminatus Pharma initiates strategic review of blockchain-integrated strategy

2025-07-22T17:35:29.000Z - 1 year ago

Liminatus Pharma initiates strategic review of blockchain-integrated strategy

Liminatus Pharma, Inc. Initiates Strategic Review of Blockchain-Integrated Treasury Strategy

Jul 22, 2025, 1:30 PM EDT - 1 year ago

Liminatus Pharma, Inc. Initiates Strategic Review of Blockchain-Integrated Treasury Strategy

Liminatus Pharma Inc trading halted, volatility trading pause

2025-06-30T14:47:52.000Z - 1 year ago

Liminatus Pharma Inc trading halted, volatility trading pause

borngifted10
borngifted10 Aug. 31 at 6:28 AM
$LIMN we are just getting murdered
0 · Reply
TNNStockAnalysisNews
TNNStockAnalysisNews Aug. 31 at 1:53 AM
Stocks Under $1 to Watch Tomorrow: Monday, August 31, 2026 $IVDA — $0.33 | Drone Line Launch Meets a Brutal 52-Week Range $LIMN — $0.18 | A Cancer Biotech Pivoting Into BNB Treasury $OTLK — $0.68 | An FDA Win Overshadowed by a Revenue Miss $ELBM — $0.63 | A Cobalt Refinery Locking In Long-Term Supply $AIM — $0.28 | An Earnings Report That Could Break the Recent Uptrend https://truthsandnews.com/markets/stocks-under-1-to-watch-this-week-aug-31-2026
0 · Reply
Najoua233902
Najoua233902 Aug. 29 at 9:35 PM
$LIMN remembered this had crazy runs before any one that traded this will know how high this went did run 1000% I Remeber
0 · Reply
The_Claw
The_Claw Aug. 28 at 8:09 PM
$LIMN Ballz is down 40% and is talking like he alone can read the tea leaves.
0 · Reply
skeezymonet
skeezymonet Aug. 28 at 5:56 PM
$LIMN at this point the September 3 Nasdaq deadline might be a light at the end of the tunnel. But thats pure hopium junkie
0 · Reply
Magik8ball2
Magik8ball2 Aug. 28 at 2:33 PM
$LIMN So this is stuck around $4.50. We need news.
1 · Reply
SHRTSQZ
SHRTSQZ Aug. 27 at 9:22 PM
$LIMN
0 · Reply
Najoua233902
Najoua233902 Aug. 27 at 2:16 PM
$YMT accumulating will shoots up as soon as the float is locked in so far so good $LIMN bottom is in $BYAH
0 · Reply
Candyfan
Candyfan Aug. 26 at 6:39 PM
$LIMN - this one will run soon, patience
2 · Reply
The_Claw
The_Claw Aug. 26 at 5:35 AM
$LIMN Cure for cancer?! $375/share?! Recovery? That pumper guy is outdoing himself.
2 · Reply
RoaringAlpha1
RoaringAlpha1 Aug. 25 at 2:57 PM
$LIMN dam what a scam scum cum
0 · Reply
The_Claw
The_Claw Aug. 24 at 6:31 PM
$LIMN The guy who was drinking falling knife milkshakes when TIPs was at .0040 and loaded the boat here with a 7 dollar average is talking smack. Okeedoke.
1 · Reply
RoaringAlpha1
RoaringAlpha1 Aug. 24 at 1:32 PM
$LIMN what a con and scam ouch
0 · Reply
STACKD0E
STACKD0E Aug. 24 at 12:30 PM
$CMND $AGIG $LIMN $NCTY $RFAI 👀
0 · Reply
Magik8ball2
Magik8ball2 Aug. 24 at 12:15 PM
$LIMN On August 24, 2026, the company announced it has engaged Synex Consulting, a Korea-based contract research organization, to support the Phase 1/2a clinical development of IBC101. IBC101 is an autologous CD19xCD22 bivalent CAR-T cell therapy candidate designed for patients with relapsed or refractory B-cell malignancies, specifically diffuse large B-cell lymphoma. The agreement utilizes a milestone-based payment structure tied to patient enrollment and study completion.
0 · Reply
borngifted10
borngifted10 Aug. 24 at 8:18 AM
$LIMN let’s have a great week!
0 · Reply
The_Claw
The_Claw Aug. 23 at 10:42 PM
$LIMN I might be desperately pumping lotto plays, too, if I sold AMFN at a nickel. Chasing the otc dragon can lead to legendary losses. Holding this one for the time being. Bust probable. Boom possible.
1 · Reply
DORO879
DORO879 Aug. 22 at 9:19 PM
$ZBAO $LGHL $LIMN $ASNS $CISS
0 · Reply
LuciaBlandy137
LuciaBlandy137 Aug. 22 at 3:42 PM
$LIMN $LOW $PR $ONDO $UAA LIMN remains highly speculative, Lowe's benefits from home-improvement spending, PR remains execution-dependent, Ondo benefits from tokenized-finance adoption, and Under Armour remains focused on brand and apparel demand. I'm watching housing activity, consumer spending, tokenization growth, and margins.
0 · Reply
Magik8ball2
Magik8ball2 Aug. 21 at 6:25 PM
$LIMN .
0 · Reply
cheapostock
cheapostock Aug. 21 at 4:42 PM
next week watchlist, boring friday but fishing needs patience!!! $PFSA $ELAB $AZTR $LIMN $VBIO 🫡
0 · Reply
TheRealShortSqueezy
TheRealShortSqueezy Aug. 21 at 2:25 PM
Few reverse splits which becomes very low floaters today $ELAB 800k float - 6.30$ $LIMN 970k float - 5.34$ $SCNI 520k float - 3.47$ $SMTK 520k float - 4.46$ $BTOG 4M - 3.59$ Remember how RCON / CISS / CXAI / PFSA all went up after their reverse split! Good luck everyone and have a good weekend!
2 · Reply